Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q15746
UPID:
MYLK_HUMAN
Alternative names:
Kinase-related protein; Telokin
Alternative UPACC:
Q15746; B4DUE3; D3DN97; O95796; O95797; O95798; O95799; Q14844; Q16794; Q17S15; Q3ZCP9; Q5MY99; Q5MYA0; Q6P2N0; Q7Z4J0; Q9C0L5; Q9UBG5; Q9UBY6; Q9UIT9
Background:
Myosin light chain kinase, smooth muscle (MLCK), also known as Kinase-related protein or Telokin, plays a pivotal role in smooth muscle contraction, cell motility, and epithelial wound healing. It achieves this through phosphorylation of myosin light chains and regulation of actin-myosin interaction. MLCK is also involved in various cellular processes including the inflammatory response, vascular permeability, and gastrointestinal motility.
Therapeutic significance:
MLCK is linked to diseases such as Aortic aneurysm, familial thoracic 7, and Megacystis-microcolon-intestinal hypoperistalsis syndrome, highlighting its potential as a target for therapeutic intervention. Understanding the role of MLCK could open doors to potential therapeutic strategies.